Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Conthram Forte
Active Ingredients: Danthron 15mg/mL
Poloxamer 188 200mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Pacific Pharmaceuticals Limited, Mt Wellington, Auckland
Note: This consent is valid for 2 years from 19 October 2004.
Product: Conthram
Active Ingredients: Danthron 5mg/mL
Poloxamer 188 40mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Pacific Pharmaceuticals Limited, Mt Wellington, Auckland
Note: This consent is valid for 2 years from 19 October 2004.
Dated this 6th day of September 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).